 | • レポートコード：GIR-2104Z14067 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、経皮スコポラミンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。経皮スコポラミンの種類別市場規模（錠剤タイプ、シロップタイプ、注射タイプ、パッチタイプ、ジェルタイプ）、用途別市場規模（麻薬性鎮痛、咳、喘息、乗り物酔い、パーキンソン病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・経皮スコポラミンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Baxter International、GlaxoSmithKline、Novartis AG、Perrigo Company、Caleb Pharmaceuticals、Myungmoon Pharma、Pfizer、Nichi-Iko ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：錠剤タイプ、シロップタイプ、注射タイプ、パッチタイプ、ジェルタイプ ・用途別分析2016年-2026年：麻薬性鎮痛、咳、喘息、乗り物酔い、パーキンソン病、その他 ・経皮スコポラミンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・経皮スコポラミンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・経皮スコポラミンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・経皮スコポラミンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・経皮スコポラミンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Transdermal Scopolamine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Transdermal Scopolamine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Transdermal Scopolamine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Transdermal Scopolamine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablet Type
Syrups Type
Injections Type
Patch Type
Gel Type
Market segment by Application can be divided into
Narcotic Analgesia
Cough
Asthma
Motion Sickness
Parkinson’s Disease
Others
The key market players for global Transdermal Scopolamine market are listed below:
Baxter International
GlaxoSmithKline
Novartis AG
Perrigo Company
Caleb Pharmaceuticals
Myungmoon Pharma
Pfizer
Nichi-Iko
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Transdermal Scopolamine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Transdermal Scopolamine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Tablet Type
1.2.3 Syrups Type
1.2.4 Injections Type
1.2.5 Patch Type
1.2.6 Gel Type
1.3 Market Analysis by Application
1.3.1 Overview: Global Transdermal Scopolamine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Narcotic Analgesia
1.3.3 Cough
1.3.4 Asthma
1.3.5 Motion Sickness
1.3.6 Parkinson’s Disease
1.3.7 Others
1.4 Global Transdermal Scopolamine Market Size & Forecast
1.4.1 Global Transdermal Scopolamine Sales in Value (2016-2026))
1.4.2 Global Transdermal Scopolamine Sales in Volume (2016-2026)
1.4.3 Global Transdermal Scopolamine Price by Type (2016-2026) & (USD/Unit)
1.5 Global Transdermal Scopolamine Production Capacity Analysis
1.5.1 Global Transdermal Scopolamine Total Production Capacity (2016-2026)
1.5.2 Global Transdermal Scopolamine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Transdermal Scopolamine Market Drivers
1.6.2 Transdermal Scopolamine Market Restraints
1.6.3 Transdermal Scopolamine Trends Analysis
2 Manufacturers Profiles
2.1 Baxter International
2.1.1 Baxter International Details
2.1.2 Baxter International Major Business
2.1.3 Baxter International Transdermal Scopolamine Product and Services
2.1.4 Baxter International Transdermal Scopolamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Transdermal Scopolamine Product and Services
2.2.4 GlaxoSmithKline Transdermal Scopolamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Transdermal Scopolamine Product and Services
2.3.4 Novartis AG Transdermal Scopolamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Perrigo Company
2.4.1 Perrigo Company Details
2.4.2 Perrigo Company Major Business
2.4.3 Perrigo Company Transdermal Scopolamine Product and Services
2.4.4 Perrigo Company Transdermal Scopolamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Caleb Pharmaceuticals
2.5.1 Caleb Pharmaceuticals Details
2.5.2 Caleb Pharmaceuticals Major Business
2.5.3 Caleb Pharmaceuticals Transdermal Scopolamine Product and Services
2.5.4 Caleb Pharmaceuticals Transdermal Scopolamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Myungmoon Pharma
2.6.1 Myungmoon Pharma Details
2.6.2 Myungmoon Pharma Major Business
2.6.3 Myungmoon Pharma Transdermal Scopolamine Product and Services
2.6.4 Myungmoon Pharma Transdermal Scopolamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Transdermal Scopolamine Product and Services
2.7.4 Pfizer Transdermal Scopolamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Nichi-Iko
2.8.1 Nichi-Iko Details
2.8.2 Nichi-Iko Major Business
2.8.3 Nichi-Iko Transdermal Scopolamine Product and Services
2.8.4 Nichi-Iko Transdermal Scopolamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Transdermal Scopolamine Sales by Manufacturer
3.1 Global Transdermal Scopolamine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Transdermal Scopolamine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Transdermal Scopolamine
3.4 Market Concentration Rate
3.4.1 Top 3 Transdermal Scopolamine Manufacturer Market Share
3.4.2 Top 6 Transdermal Scopolamine Manufacturer Market Share
3.5 Global Transdermal Scopolamine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Transdermal Scopolamine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Transdermal Scopolamine Market Size by Region
4.1.1 Global Transdermal Scopolamine Sales in Volume by Region (2016-2026)
4.1.2 Global Transdermal Scopolamine Revenue by Region (2016-2026)
4.2 North America Transdermal Scopolamine Revenue (2016-2026)
4.3 Europe Transdermal Scopolamine Revenue (2016-2026)
4.4 Asia-Pacific Transdermal Scopolamine Revenue (2016-2026)
4.5 South America Transdermal Scopolamine Revenue (2016-2026)
4.6 Middle East and Africa Transdermal Scopolamine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Transdermal Scopolamine Sales in Volume by Type (2016-2026)
5.2 Global Transdermal Scopolamine Revenue by Type (2016-2026)
5.3 Global Transdermal Scopolamine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Transdermal Scopolamine Sales in Volume by Application (2016-2026)
6.2 Global Transdermal Scopolamine Revenue by Application (2016-2026)
6.3 Global Transdermal Scopolamine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Transdermal Scopolamine Sales by Type (2016-2026)
7.2 North America Transdermal Scopolamine Sales by Application (2016-2026)
7.3 North America Transdermal Scopolamine Market Size by Country
7.3.1 North America Transdermal Scopolamine Sales in Volume by Country (2016-2026)
7.3.2 North America Transdermal Scopolamine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Transdermal Scopolamine Sales by Type (2016-2026)
8.2 Europe Transdermal Scopolamine Sales by Application (2016-2026)
8.3 Europe Transdermal Scopolamine Market Size by Country
8.3.1 Europe Transdermal Scopolamine Sales in Volume by Country (2016-2026)
8.3.2 Europe Transdermal Scopolamine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Transdermal Scopolamine Sales by Type (2016-2026)
9.2 Asia-Pacific Transdermal Scopolamine Sales by Application (2016-2026)
9.3 Asia-Pacific Transdermal Scopolamine Market Size by Region
9.3.1 Asia-Pacific Transdermal Scopolamine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Transdermal Scopolamine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Transdermal Scopolamine Sales by Type (2016-2026)
10.2 South America Transdermal Scopolamine Sales by Application (2016-2026)
10.3 South America Transdermal Scopolamine Market Size by Country
10.3.1 South America Transdermal Scopolamine Sales in Volume by Country (2016-2026)
10.3.2 South America Transdermal Scopolamine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Transdermal Scopolamine Sales by Type (2016-2026)
11.2 Middle East & Africa Transdermal Scopolamine Sales by Application (2016-2026)
11.3 Middle East & Africa Transdermal Scopolamine Market Size by Country
11.3.1 Middle East & Africa Transdermal Scopolamine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Transdermal Scopolamine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Transdermal Scopolamine Typical Distributors
12.3 Transdermal Scopolamine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Transdermal Scopolamine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Transdermal Scopolamine Revenue by Application, (USD Million), 2021-2026
Table 3. Baxter International Basic Information, Manufacturing Base and Competitors
Table 4. Baxter International Major Business
Table 5. Baxter International Transdermal Scopolamine Product and Services
Table 6. Baxter International Transdermal Scopolamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Major Business
Table 9. GlaxoSmithKline Transdermal Scopolamine Product and Services
Table 10. GlaxoSmithKline Transdermal Scopolamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 12. Novartis AG Major Business
Table 13. Novartis AG Transdermal Scopolamine Product and Services
Table 14. Novartis AG Transdermal Scopolamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Perrigo Company Basic Information, Manufacturing Base and Competitors
Table 16. Perrigo Company Major Business
Table 17. Perrigo Company Transdermal Scopolamine Product and Services
Table 18. Perrigo Company Transdermal Scopolamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Caleb Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Caleb Pharmaceuticals Major Business
Table 21. Caleb Pharmaceuticals Transdermal Scopolamine Product and Services
Table 22. Caleb Pharmaceuticals Transdermal Scopolamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Myungmoon Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Myungmoon Pharma Major Business
Table 25. Myungmoon Pharma Transdermal Scopolamine Product and Services
Table 26. Myungmoon Pharma Transdermal Scopolamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Pfizer Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer Major Business
Table 29. Pfizer Transdermal Scopolamine Product and Services
Table 30. Pfizer Transdermal Scopolamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Nichi-Iko Basic Information, Manufacturing Base and Competitors
Table 32. Nichi-Iko Major Business
Table 33. Nichi-Iko Transdermal Scopolamine Product and Services
Table 34. Nichi-Iko Transdermal Scopolamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Transdermal Scopolamine Sales by Manufacturer (2019-2021e) & (K Units)
Table 36. Global Transdermal Scopolamine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Transdermal Scopolamine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Transdermal Scopolamine Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Transdermal Scopolamine Production Site of Key Manufacturer
Table 40. Global Transdermal Scopolamine Sales by Region (2016-2021e) & (K Units)
Table 41. Global Transdermal Scopolamine Sales by Region (2021-2026) & (K Units)
Table 42. Global Transdermal Scopolamine Revenue by Region (2016-2021e) & (USD Million)
Table 43. Global Transdermal Scopolamine Revenue by Region (2021-2026) & (USD Million)
Table 44. Global Transdermal Scopolamine Sales by Type (2016-2021e) & (K Units)
Table 45. Global Transdermal Scopolamine Sales by Type (2021-2026) & (K Units)
Table 46. Global Transdermal Scopolamine Revenue by Type (2016-2021e) & (USD Million)
Table 47. Global Transdermal Scopolamine Revenue by Type (2021-2026) & (USD Million)
Table 48. Global Transdermal Scopolamine Price by Type (2016-2021e) & (USD/Unit)
Table 49. Global Transdermal Scopolamine Price by Type (2021-2026) & (USD/Unit)
Table 50. Global Transdermal Scopolamine Sales by Application (2016-2021e) & (K Units)
Table 51. Global Transdermal Scopolamine Sales by Application (2021-2026) & (K Units)
Table 52. Global Transdermal Scopolamine Revenue by Application (2016-2021e) & (USD Million)
Table 53. Global Transdermal Scopolamine Revenue by Application (2021-2026) & (USD Million)
Table 54. Global Transdermal Scopolamine Price by Application (2016-2021e) & (USD/Unit)
Table 55. Global Transdermal Scopolamine Price by Application (2021-2026) & (USD/Unit)
Table 56. North America Transdermal Scopolamine Sales by Country (2016-2021e) & (K Units)
Table 57. North America Transdermal Scopolamine Sales by Country (2021-2026) & (K Units)
Table 58. North America Transdermal Scopolamine Revenue by Country (2016-2021e) & (USD Million)
Table 59. North America Transdermal Scopolamine Revenue by Country (2021-2026) & (USD Million)
Table 60. North America Transdermal Scopolamine Sales by Type (2016-2021e) & (K Units)
Table 61. North America Transdermal Scopolamine Sales by Type (2021-2026) & (K Units)
Table 62. North America Transdermal Scopolamine Sales by Application (2016-2021e) & (K Units)
Table 63. North America Transdermal Scopolamine Sales by Application (2021-2026) & (K Units)
Table 64. Europe Transdermal Scopolamine Sales by Country (2016-2021e) & (K Units)
Table 65. Europe Transdermal Scopolamine Sales by Country (2021-2026) & (K Units)
Table 66. Europe Transdermal Scopolamine Revenue by Country (2016-2021e) & (USD Million)
Table 67. Europe Transdermal Scopolamine Revenue by Country (2021-2026) & (USD Million)
Table 68. Europe Transdermal Scopolamine Sales by Type (2016-2021e) & (K Units)
Table 69. Europe Transdermal Scopolamine Sales by Type (2021-2026) & (K Units)
Table 70. Europe Transdermal Scopolamine Sales by Application (2016-2021e) & (K Units)
Table 71. Europe Transdermal Scopolamine Sales by Application (2021-2026) & (K Units)
Table 72. Asia-Pacific Transdermal Scopolamine Sales by Region (2016-2021e) & (K Units)
Table 73. Asia-Pacific Transdermal Scopolamine Sales by Region (2021-2026) & (K Units)
Table 74. Asia-Pacific Transdermal Scopolamine Revenue by Region (2016-2021e) & (USD Million)
Table 75. Asia-Pacific Transdermal Scopolamine Revenue by Region (2021-2026) & (USD Million)
Table 76. Asia-Pacific Transdermal Scopolamine Sales by Type (2016-2021e) & (K Units)
Table 77. Asia-Pacific Transdermal Scopolamine Sales by Type (2021-2026) & (K Units)
Table 78. Asia-Pacific Transdermal Scopolamine Sales by Application (2016-2021e) & (K Units)
Table 79. Asia-Pacific Transdermal Scopolamine Sales by Application (2021-2026) & (K Units)
Table 80. South America Transdermal Scopolamine Sales by Country (2016-2021e) & (K Units)
Table 81. South America Transdermal Scopolamine Sales by Country (2021-2026) & (K Units)
Table 82. South America Transdermal Scopolamine Revenue by Country (2016-2021e) & (USD Million)
Table 83. South America Transdermal Scopolamine Revenue by Country (2021-2026) & (USD Million)
Table 84. South America Transdermal Scopolamine Sales by Type (2016-2021e) & (K Units)
Table 85. South America Transdermal Scopolamine Sales by Type (2021-2026) & (K Units)
Table 86. South America Transdermal Scopolamine Sales by Application (2016-2021e) & (K Units)
Table 87. South America Transdermal Scopolamine Sales by Application (2021-2026) & (K Units)
Table 88. Middle East & Africa Transdermal Scopolamine Sales by Country (2016-2021e) & (K Units)
Table 89. Middle East & Africa Transdermal Scopolamine Sales by Country (2021-2026) & (K Units)
Table 90. Middle East & Africa Transdermal Scopolamine Revenue by Country (2016-2021e) & (USD Million)
Table 91. Middle East & Africa Transdermal Scopolamine Revenue by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Transdermal Scopolamine Sales by Type (2016-2021e) & (K Units)
Table 93. Middle East & Africa Transdermal Scopolamine Sales by Type (2021-2026) & (K Units)
Table 94. Middle East & Africa Transdermal Scopolamine Sales by Application (2016-2021e) & (K Units)
Table 95. Middle East & Africa Transdermal Scopolamine Sales by Application (2021-2026) & (K Units)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Transdermal Scopolamine Typical Distributors
Table 99. Transdermal Scopolamine Typical Customers
List of Figures
Figure 1. Transdermal Scopolamine Picture
Figure 2. Global Transdermal Scopolamine Sales Market Share by Type in 2020
Figure 3. Tablet Type
Figure 4. Syrups Type
Figure 5. Injections Type
Figure 6. Patch Type
Figure 7. Gel Type
Figure 8. Global Transdermal Scopolamine Sales Market Share by Application in 2020
Figure 9. Narcotic Analgesia
Figure 10. Cough
Figure 11. Asthma
Figure 12. Motion Sickness
Figure 13. Parkinson's Disease
Figure 14. Others
Figure 15. Global Transdermal Scopolamine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 16. Global Transdermal Scopolamine Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. United States Transdermal Scopolamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Canada Transdermal Scopolamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Mexico Transdermal Scopolamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Germany Transdermal Scopolamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. France Transdermal Scopolamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. United Kingdom Transdermal Scopolamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Russia Transdermal Scopolamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Italy Transdermal Scopolamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. China Transdermal Scopolamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Japan Transdermal Scopolamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Korea Transdermal Scopolamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. India Transdermal Scopolamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Southeast Asia Transdermal Scopolamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Australia Transdermal Scopolamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Brazil Transdermal Scopolamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Egypt Transdermal Scopolamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Saudi Arabia Transdermal Scopolamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. South Africa Transdermal Scopolamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Turkey Transdermal Scopolamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Global Transdermal Scopolamine Sales (2016-2026) & (K Units)
Figure 37. Global Transdermal Scopolamine Production Capacity (2016-2026) & (K Units)
Figure 38. Global Transdermal Scopolamine Production Capacity by Geographic Region: 2020 VS 2021
Figure 39. Transdermal Scopolamine Market Drivers
Figure 40. Transdermal Scopolamine Market Restraints
Figure 41. Transdermal Scopolamine Market Trends
Figure 42. Global Transdermal Scopolamine Sales Market Share by Manufacturer in 2020
Figure 43. Global Transdermal Scopolamine Revenue Market Share by Manufacturer in 2020
Figure 44. Transdermal Scopolamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 45. Top 3 Transdermal Scopolamine Manufacturer (Revenue) Market Share in 2020
Figure 46. Top 6 Transdermal Scopolamine Manufacturer (Revenue) Market Share in 2020
Figure 47. Global Transdermal Scopolamine Sales Market Share by Region (2016-2026)
Figure 48. Global Transdermal Scopolamine Revenue Market Share by Region (2016-2026)
Figure 49. North America Transdermal Scopolamine Revenue (2016-2026) & (USD Million)
Figure 50. Europe Transdermal Scopolamine Revenue (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Transdermal Scopolamine Revenue (2016-2026) & (USD Million)
Figure 52. South America Transdermal Scopolamine Revenue (2016-2026) & (USD Million)
Figure 53. Middle East & Africa Transdermal Scopolamine Revenue (2016-2026) & (USD Million)
Figure 54. Global Transdermal Scopolamine Sales Market Share by Type (2016-2026)
Figure 55. Global Transdermal Scopolamine Revenue Market Share by Type (2016-2026)
Figure 56. Global Transdermal Scopolamine Price by Type (2016-2026) & (USD/Unit)
Figure 57. Global Transdermal Scopolamine Sales Market Share by Application (2016-2026)
Figure 58. Global Transdermal Scopolamine Revenue Market Share by Application (2016-2026)
Figure 59. Global Transdermal Scopolamine Price by Application (2016-2026) & (USD/Unit)
Figure 60. North America Transdermal Scopolamine Sales Market Share by Country (2016-2026)
Figure 61. North America Transdermal Scopolamine Revenue Market Share by Country (2016-2026)
Figure 62. North America Transdermal Scopolamine Sales Market Share by Type (2016-2026)
Figure 63. North America Transdermal Scopolamine Sales Market Share by Application (2016-2026)
Figure 64. Europe Transdermal Scopolamine Sales Market Share by Country (2016-2026)
Figure 65. Europe Transdermal Scopolamine Revenue Market Share by Country (2016-2026)
Figure 66. Europe Transdermal Scopolamine Sales Market Share by Type (2016-2026)
Figure 67. Europe Transdermal Scopolamine Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Transdermal Scopolamine Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Transdermal Scopolamine Revenue Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Transdermal Scopolamine Sales Market Share by Region (2016-2026)
Figure 71. Asia-Pacific Transdermal Scopolamine Sales Market Share by Application (2016-2026)
Figure 72. South America Transdermal Scopolamine Sales Market Share by Country (2016-2026)
Figure 73. South America Transdermal Scopolamine Revenue Market Share by Country (2016-2026)
Figure 74. South America Transdermal Scopolamine Sales Market Share by Type (2016-2026)
Figure 75. South America Transdermal Scopolamine Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Transdermal Scopolamine Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Transdermal Scopolamine Revenue Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Transdermal Scopolamine Sales Market Share by Type (2016-2026)
Figure 79. Middle East & Africa Transdermal Scopolamine Sales Market Share by Application (2016-2026)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界のニコチン経皮パッチ市場 2021：企業別、地域別、種類・用途別 The Nicotine Transdermal Patches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…- 世界のリバスチグミン経皮パッチ市場 2021：企業別、地域別、種類・用途別 The Rivastigmine Transdermal Patches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界のフェンタニル経皮パッチ市場 2021：企業別、地域別、種類・用途別 The Fentanyl Transdermal Patches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界のエストラジオール経皮システム市場規模・現状・予測（2021年-2027年） Estradiol is in a class of medications called estrogen hormones. It works by replacing estrogen that is normally produced by the body. Most brands of estradiol transdermal patches are used to treat hot flushes (hot flashes; sudden strong feelings of heat and sweating) and/or vaginal dryness, itching…
- 世界のブプレノルフィン経皮パッチ市場 2021：企業別、地域別、種類・用途別 The Buprenorphine Transdermal Patches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…